Skip to main content
رجوع
LH logo

Labcorp Holdings Inc.

جودة البيانات: 100%
LH
NYSE Healthcare Medical - Diagnostics & Research
KWD 266.02
▼ KWD 0.10 (-0.04%)
القيمة السوقية: 22.05B
نطاق اليوم
KWD 265.47 KWD 269.97
نطاق 52 أسبوعًا
KWD 209.38 KWD 293.72
حجم التداول
474,904
متوسط 50 يوم / 200 يوم
KWD 272.78 / KWD 267.35
الإغلاق السابق
KWD 266.12

Quick Summary

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (627 نظير)

المقياس السهم وسيط القطاع
P/E 25.2 0.3
P/B 2.6 3.0
ROE % 10.5 3.7
Net Margin % 6.3 3.8
Rev Growth 5Y % 1.5 10.0
D/E 0.8 0.2

السعر المستهدف للمحللين

Hold
KWD 315.38 +18.6%
Low: KWD 290.00 High: KWD 342.00
مكرر الربحية المستقبلي
14.89
ربحية السهم المستقبلية
KWD 17.86
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
14.67B

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 23.80
KWD 23.42 – KWD 24.14
15.22B 1
FY2029 KWD 23.23
KWD 22.85 – KWD 23.56
17.34B 1
FY2028 KWD 21.07
KWD 19.66 – KWD 23.85
16.18B 5

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-02-17 KWD 3.95 KWD 4.07 +3.0%
2025-10-28 KWD 4.13 KWD 4.18 +1.2%
2025-07-24 KWD 4.17 KWD 4.35 +4.3%
2025-04-29 KWD 3.74 KWD 3.84 +2.7%
2025-02-06 KWD 3.39 KWD 3.45 +1.8%
2024-10-24 KWD 3.47 KWD 3.50 +0.9%
2024-08-01 KWD 3.78 KWD 3.94 +4.2%
2024-04-25 KWD 3.48 KWD 3.68 +5.7%

Dividend History

4 yr streak

Yield

0.01%

Payout Ratio

0.27%

Growth (3Y)

10.06%

Growth (5Y)

N/A

Ex-Date Payment Date Amount Yield
Feb 27, 2026 Mar 12, 2026 KWD 0.72 1.00%
Nov 26, 2025 Dec 11, 2025 KWD 0.72 1.07%
Aug 28, 2025 Sep 11, 2025 KWD 0.72 1.05%
May 29, 2025 Jun 11, 2025 KWD 0.72 1.17%
Feb 27, 2025 Mar 12, 2025 KWD 0.72 1.16%
Nov 26, 2024 Dec 13, 2024 KWD 0.72 1.21%
Aug 29, 2024 Sep 13, 2024 KWD 0.72 1.25%
May 24, 2024 Jun 12, 2024 KWD 0.72 1.44%
Feb 26, 2024 Mar 13, 2024 KWD 0.72 1.29%
Nov 07, 2023 Dec 12, 2023 KWD 0.72 1.29%
Aug 07, 2023 Sep 08, 2023 KWD 0.72 1.20%
May 17, 2023 Jun 08, 2023 KWD 0.72 1.33%
Feb 22, 2023 Mar 13, 2023 KWD 0.72 1.19%
Nov 16, 2022 Dec 09, 2022 KWD 0.72 0.89%
Aug 17, 2022 Sep 09, 2022 KWD 0.72 0.57%
May 18, 2022 Jun 09, 2022 KWD 0.72 0.30%
Mar 29, 1994 Apr 26, 1994 KWD 0.08 2.37%
Dec 29, 1993 Jan 25, 1994 KWD 0.08 2.31%
Sep 29, 1993 Oct 26, 1993 KWD 0.08 2.06%
Jun 29, 1993 Jul 27, 1993 KWD 0.08 1.78%

النقاط الرئيسية

Revenue grew 1.52% annually over 5 years — modest growth
Earnings grew 17.49% over the past year
ROE of 10.51% — decent returns on equity
Generating 1.21B in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 5.73%
Cash machine — converts 137.59% of earnings into free cash flow

النمو

Revenue Growth (5Y)
1.52%
Revenue (1Y)7.25%
Earnings (1Y)17.49%
FCF Growth (3Y)17.46%

الجودة

Return on Equity
10.51%
ROIC7.19%
Net Margin6.28%
Op. Margin10.87%

الأمان

Debt / Equity
0.84
Current Ratio1.42
Interest Coverage6.77

التقييم

P/E Ratio
25.16
Forward P/E14.89
P/B Ratio2.56
EV/EBITDA18.95
Dividend Yield0.01%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 7.25% Revenue Growth (3Y) 7.11%
Earnings Growth (1Y) 17.49% Earnings Growth (3Y) 44.81%
Revenue Growth (5Y) 1.52% Earnings Growth (5Y) -22.08%
Profitability
Revenue (TTM) 13.95B Net Income (TTM) 876.50M
ROE 10.51% ROA 4.77%
Gross Margin 26.75% Operating Margin 10.87%
Net Margin 6.28% Free Cash Flow (TTM) 1.21B
ROIC 7.19% FCF Growth (3Y) 17.46%
Safety
Debt / Equity 0.84 Current Ratio 1.42
Interest Coverage 6.77
Dividends
Dividend Yield 0.01% Payout Ratio 0.27%
Dividend Growth (3Y) 10.06% Dividend Growth (5Y) N/A
Consecutive Div Years 4 yrs
Valuation
P/E Ratio 25.16 Forward P/E 14.89
P/B Ratio 2.56 P/S Ratio 1.58
PEG Ratio 1.28 Forward PEG N/A
EV/EBITDA 18.95 Fwd EV/EBITDA 11.67
Forward P/S 1.50 Fwd Earnings Yield 6.72%
FCF Yield 5.47%
Market Cap 22.05B Enterprise Value 28.72B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 13.95B 13.01B 12.16B 11.86B 13.14B
Net Income 876.50M 746.00M 418.00M 1.28B 2.38B
EPS (Diluted) 10.46 8.84 4.77 13.96 24.38
Gross Profit 3.73B 3.62B 3.36B 3.71B 4.99B
Operating Income 1.52B 1.09B 725.60M 1.44B 3.05B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 18.39B 18.38B 16.73B 20.16B 20.39B
Total Liabilities 9.76B 10.31B 8.83B 10.04B 10.09B
Shareholders' Equity 8.62B 8.05B 7.88B 10.10B 10.27B
Total Debt 7.20B 7.27B 5.95B 6.25B 6.34B
Cash & Equivalents 532.30M 1.52B 536.80M 320.60M 1.47B
Current Assets 4.02B 4.81B 3.77B 4.63B 5.33B
Current Liabilities 2.82B 3.33B 3.23B 3.08B 2.78B

درجات الاستراتيجيات

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
#626 of 1052
40

النشاط الأخير

دخل Cash Flow Compounder
Mar 24, 2026